Position in HLN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$28,073
-$2,047 QoQ
Shares Held
3,009
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#431
of 639 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $134,156 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (20.9% of the industry book) .
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,073 | 3,009 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $30,120 | 3,009 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $30,420 | 3,009 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $26,990 | 3,009 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $31,203 | 3,009 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $30,962 | 3,009 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $28,705 | 3,009 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $27,254 | 2,576 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $22,302 | 2,700 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $22,923 | 2,700 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $24,772 | 3,010 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $26,531 | 3,185 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $26,690 | 3,185 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $28,660 | 3,521 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $38,408 | 4,801 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||